Hinokiol

Hinokiol
Product Name Hinokiol
CAS No.: 564-73-8
Catalog No.: CFN98948
Molecular Formula: C20H30O2
Molecular Weight: 302.5 g/mol
Purity: >=98%
Type of Compound: Diterpenoids
Physical Desc.: Powder
Targets: LOX | NO | TNF-α | COX | Antifection | LTB
Source: The barks of Cephalotaxus fortunei Hook. f.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Hinokiol has anti-inflammatory activity, it has significant inhibitory effects on 5-hydroxy-eicosa-tetra-enoic acid (5-HETE) and leukotriene B(4) (LTB4) formations. Hinokiol demonstrates potent activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Evid Based Complement Alternat Med.2018, 2018:1073509
  • Cancers (Basel).2023, 15(1):293.
  • J AOAC Int.2021, 104(6):1634-1651.
  • Appl. Sci.2020, 10,1304
  • Anticancer Agents Med Chem.2023, 23(10):1204-1210.
  • Front Plant Sci.2020, 10:1705
  • J Ethnopharmacol.2017, 206:327-336
  • Korean J. Medicinal Crop Sci.2018, 26(2):148-156
  • Appl. Sci.2020, 10(16),5482.
  • Mol Pharm.2017, 14(9):3164-3177
  • Benzaldehyden

    Catalog No: CFN92677
    CAS No: 1072444-55-3
    Price: Inquiry(manager@chemfaces.com)
    Wulfenioidin G

    Catalog No: CFN95816
    CAS No: N/A
    Price: $318/5mg
    Isodon B

    Catalog No: CFN95829
    CAS No: N/A
    Price: $413/5mg
    5alpha,6-Dihydro-15-methoxysalviasperanol

    Catalog No: CFN95834
    CAS No: N/A
    Price: $413/5mg
    Ferruginol

    Catalog No: CFN92178
    CAS No: 514-62-5
    Price: Inquiry(manager@chemfaces.com)
    15-Hydroxyferruginol

    Catalog No: CFN92329
    CAS No: 76235-93-3
    Price: Inquiry(manager@chemfaces.com)
    Hinokiol

    Catalog No: CFN98948
    CAS No: 564-73-8
    Price: Inquiry(manager@chemfaces.com)
    3alpha-Hinokiol

    Catalog No: CFN95814
    CAS No: 107740-34-1
    Price: $318/5mg
    2beta-Acetoxyferruginol

    Catalog No: CFN92978
    CAS No: 1206461-56-4
    Price: Inquiry(manager@chemfaces.com)
    Sugiol

    Catalog No: CFN92187
    CAS No: 511-05-7
    Price: Inquiry(manager@chemfaces.com)
    J Ethnopharmacol. 2012 Jun 1;141(2):647-52.
    The anti-inflammatory activities of an extract and compounds isolated from Platycladus orientalis (Linnaeus) Franco in vitro and ex vivo.[Pubmed: 21619922]
    As a Chinese traditional herbal medicine, leaves of Platycladus orientalis (Linnaeus) Franco (LPO) are used to treat coughs, excessive mucus secretion, chronic bronchitis, bronchiectasis, and asthma, etc. The experiments were carried out to investigate their anti-inflammatory properties and mechanisms, which could support the Chinese traditional uses of treating inflammatory airway diseases.
    METHODS AND RESULTS:
    The anti-inflammatory activities of the chloroform fraction (CHL) and pure compounds of LPO were evaluated for their abilities to inhibit pro-inflammatory enzymes in vitro, and production of tumor necrosis factor-α (TNF-α) and nitric oxide in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Furthermore, the arachidonic acid metabolites, stimulated by calcium ionophore A23187, were also determined by HPLC. For the first time, the assays of eicosanoids in intact cells showed that the CHL, Hinokiol, and acacetin had significant inhibitory effects on 5-hydroxy-eicosa-tetra-enoic acid (5-HETE) and leukotriene B(4) (LTB4) formations. And cell-free enzyme assays (5-lipoxygenase, leukotriene A(4)-hydrolase, cyclooxgenase-2) demonstrated the potent inhibitory effects of the CHL, Hinokiol and acacetin on 5-lipoxygenase (5-LOX). Then, the inhibitions of the CHL, Hinokiol on NO biosynthesis and the inhibitions of the CHL, 8(14),15-pimaradien-3β,18-diol, and Hinokiol on TNF-α release were also confirmed in the RAW264.7 murine macrophages.
    CONCLUSIONS:
    The data indicate that the inhibitory effects of the CHL and its components (Hinokiol and acacetin) on 5-LOX contribute to the anti-inflammatory activity of LPO. Moreover, the CHL and its components also show beneficial effects on NO and TNF-α production. Consequently, these results provide a rationale for LPO's traditional applications in the treatment of inflammatory airway diseases.
    Nat Prod Commun. 2014 Aug;9(8):1129-30.
    Antibacterial activity of Taxodium ascendens diterpenes against methicillin-resistant Staphylococcus aureus.[Pubmed: 25233589]

    METHODS AND RESULTS:
    One new and seven known diterpenes were identified from an antibacterial chromatographic fraction of Taxodium ascendens. Of these, demethylcryptojaponol (2), 6-hydroxysalvinolone (3), hydroxyferruginol (4), and Hinokiol (5) demonstrated potent activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    CONCLUSIONS:
    These compounds represent a class of synthetically accessible compounds that could be further developed for treatment of drug-resistant bacterial infections.
    4-Hydroxybenzoyl choline

    Catalog No: CFN95158
    CAS No: 5094-31-5
    Price: $318/20mg
    Apigenin 7-O-(6''-O-malonylglucoside)

    Catalog No: CFN95163
    CAS No: 86546-87-4
    Price: $318/5mg
    Isoeuphorbetin

    Catalog No: CFN95207
    CAS No: 50677-55-9
    Price: $318/5mg
    Polygalacin D2

    Catalog No: CFN95241
    CAS No: 66663-92-1
    Price: $413/5mg
    Safflospermidine A

    Catalog No: CFN95255
    CAS No: 1111082-13-3
    Price: $413/5mg
    Quercetin-3'-glucoside

    Catalog No: CFN95271
    CAS No: 19254-30-9
    Price: $318/10mg
    Quercetin 3-O-beta-D-glucosyl-(1->2)-rhamnoside

    Catalog No: CFN95277
    CAS No: 143016-74-4
    Price: $238/20mg
    1-(3',5'-dimethoxy)phenyl-2-[4''-O-beta-D-glucopyranosyl (6->1)-O-alpha-L-rhamnopyranosyl]phenylethane

    Catalog No: CFN95285
    CAS No: 1338076-61-1
    Price: $413/5mg
    Hosenkoside L

    Catalog No: CFN95520
    CAS No: 161016-50-8
    Price: $318/10mg
    Methyl ganoderate F

    Catalog No: CFN95584
    CAS No: 98665-08-8
    Price: $368/5mg